{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:26:39Z","timestamp":1769124399176,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":2329,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.jacc.2006.10.059","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T12:16:43Z","timestamp":1172060203000},"page":"963-971","source":"Crossref","is-referenced-by-count":48,"title":["Carvedilol Protects Better Against Vascular Events Than Metoprolol in Heart Failure"],"prefix":"10.1016","volume":"49","author":[{"given":"Willem J.","family":"Remme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.F.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Poole-Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Komajda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Swedberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Di Lenarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Spark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Scherhag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Moullet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2006.10.059_bib1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2006.10.059_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2006.10.059_bib3","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in congestive heart failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2006.10.059_bib4","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2006.10.059_bib5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0735-1097(97)00012-0","article-title":"Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease","volume":"29","author":"Doughty","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.10.059_bib6","first-page":"57","article-title":"The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction","volume":"18","author":"Remme","year":"2004","journal-title":"The Carvedilol and Ace-inhibitor Remodelling Mild heart failure EvaluatioN trial (CARMEN)Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2006.10.059_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2006.10.059_bib8","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1161\/01.CIR.0000130849.08704.24","article-title":"Carvedilol but not metoprolol reduces \u03b2-adrenergic responsiveness after complete elimination from plasma in vivo","volume":"109","author":"Kindermann","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.10.059_bib9","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/01.CIR.96.6.1914","article-title":"Beta 2-adrenergic receptor antagonists protect against ventricular fibrillation","volume":"96","author":"Billman","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.10.059_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/01.CIR.101.1.71","article-title":"\u03b22-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis","volume":"101","author":"Du","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.10.059_bib11","first-page":"245","article-title":"Alpha-1 adrenoceptor subtypes involved in mediating adrenergically induced antinatriuresis and antidiuresis in two kidney, one clip Goldblatt and deoxycorticosterone acetate-salt hypertensive rats","volume":"277","author":"Sattar","year":"1996","journal-title":"J Pharmcol Exp Ther"},{"key":"10.1016\/j.jacc.2006.10.059_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1388-9842(02)00025-9","article-title":"Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET","volume":"4","author":"Poole-Wilson","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2006.10.059_bib13","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0735-1097(99)00134-5","article-title":"Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol","volume":"33","author":"Di Lenarda","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.10.059_bib14","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0735-1097(99)00367-8","article-title":"Beta-blockade in heart failure","volume":"34","author":"Sanderson","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.10.059_bib15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/01.CIR.102.5.546","article-title":"Differential effects of beta-blockers in patients with heart failure","volume":"102","author":"Metra","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.10.059_bib16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1067\/mhj.2001.115584","article-title":"Comparative effects or carvedilol and metoprolol on left ventricular ejection fraction in heart failure: a meta-analysis","volume":"141","author":"Packer","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2006.10.059_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2004.09.076","article-title":"Antiarrhythmic effect of carvedilol after acute myocardial infarction","volume":"45","author":"McMurray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.10.059_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/080370500448687","article-title":"Divergent effects of different beta-blocking agents on endothelin-dependent vasodilatation in the human forearm","volume":"9","author":"Von zur Muhlen","year":"2000","journal-title":"Blood Press"},{"key":"10.1016\/j.jacc.2006.10.059_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.CIR.0000085070.39873.B1","article-title":"Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure","volume":"108","author":"Hryniewicz","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.10.059_bib20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00005344-200005000-00013","article-title":"Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries","volume":"35","author":"Intengan","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2006.10.059_bib21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1067\/mhj.2000.110093","article-title":"Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease","volume":"140","author":"Matsuda","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2006.10.059_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000139331","article-title":"Carvedilol, a new beta-adrenoceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction","volume":"51","author":"Lopez","year":"1995","journal-title":"Pharmacology"},{"key":"10.1016\/j.jacc.2006.10.059_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(00)00641-5","article-title":"Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model","volume":"406","author":"Gao","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacc.2006.10.059_bib24","first-page":"128","article-title":"Carvedilol, a new beta-adrenoceptor blocker and free radical scavenger attenuates myocardial ischemia reperfusion injury in hypercholesterolemic rabbits","volume":"277","author":"Ma","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2006.10.059_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00005344-199809000-00015","article-title":"Comparative effects of carvedilol and metoprolol on cardiac ischemia-reperfusion injury","volume":"32","author":"Khandoudi","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2006.10.059_bib26","first-page":"1447","article-title":"Impact of carvedilol on the mitochondrial damage induced by hypoxanthine and xanthine oxidase\u2014what role in myocardial ischemia and reperfusion?","volume":"21","author":"Oliveira","year":"2002","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.jacc.2006.10.059_bib27","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1161\/01.CIR.0000130917.12959.04","article-title":"Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts","volume":"109","author":"Asanuma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.10.059_bib28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0008-6363(99)00369-7","article-title":"Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas\/Fas ligand and caspase-3 pathway","volume":"45","author":"Romeo","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2006.10.059_bib29","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0735-1097(00)01002-0","article-title":"Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol","volume":"36","author":"Rossig","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.10.059_bib30","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1161\/01.ATV.0000145016.69181.fa","article-title":"Carvedilol inhibits tumor necrosis factor-alpha-induced endothelial transcription factor activation, adhesion molecule expression and adhesiveness to human mononuclear cells","volume":"24","author":"Chen","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2006.10.059_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00005344-200007000-00013","article-title":"Differential effects of carvedilol on norepinephrine release in normoxic and ischemic heart","volume":"36","author":"Kurz","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2006.10.059_bib32","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1093\/eurheartj\/ehi386","article-title":"Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial","volume":"26","author":"Metra","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2006.10.059_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(03)13801-9","article-title":"Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised, controlled trial","volume":"362","author":"Cleland","year":"2003","journal-title":"Lancet"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510970603021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510970603021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T06:22:42Z","timestamp":1547014962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510970603021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S073510970603021X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2006.10.059","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}